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Al&Tact 
Protein transport across the endoplasmic reticulum membrane in eukaryotes and across the cytoplasmic membrane in bacteria have turned out 
to be highly related. The core component of the translocation apparatus is the Sec6USecYp complex; at least two of its subunits are conserved in 
evolution. The Sec6llSecYp complex is involved in both co- and post-translational transport pathways. The two modes require probably distinct 
additional components. 
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1. lntruduction 
The secretion of proteins from cells is a ubiquitous 
process. In prokaryotes, secretory proteins are trans- 
ferred directly across the plasma membrane whereas in 
eukaryotes, they are first translocated in an analogous 
process across the endoplasmic reticulum (ER) mem- 
brane, but are subsequently transported in vesicles to the 
plasma membrane. Similar pathways are used by mem- 
brane proteins. In all organisms, the translocation of 
proteins across, and their integration into, the membrane 
are triggered by hydrophobic signal sequences which are 
interchangeable; prokaryotic signal sequences can func- 
tion in eukaryotes and vice versa. Whereas signal se- 
quences of secretory proteins are often cleavable, those 
of membrane proteins may serve as permanent mem- 
brane anchors. Membrane anchoring may also involve 
additional hydrophobic sequences. 
The transport of a protein across the membrane may 
occur during its synthesis (co-translationally) or after its 
completion (post-translationally). In both cases, the 
process is initiated by a targeting phase (for review, see 
[l]). One mechanism of co-translational targeting in- 
volves the signal recognition particle (SRP) which only 
recognizes signal sequences of nascent chains that are 
bound to the ribosome. Other targeting pathways in- 
volve cytosolic chaperones uch as SecB, groEL and hsp 
70, which may function either co- or post-translationally 
and which keep polypeptides in a translocation-compe- 
tent conformation. 
The mechanism of the actual translocation process 
that follows the targeting phase also seems to differ de- 
pending on whether the polypeptide is transported co- or 
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post-translationally. The co-translational mode requires 
the binding of the translating ribosome to the membrane 
and it is believed that the elongating nascent chain is 
transferred directly from the ribosome into the mem- 
brane [2]. Thus, the membrane binding of the ribosome 
may be instrumental for the translocation process. In 
contrast, since the ribosome does not play a role in the 
post-translational mode of translocation of proteins, 
other mechanisms of transport may be postulated. In 
both cases, however, it is thought that polypeptides are 
transferred across the membrane through a protein-con- 
ducting channel, formed at least in part from transmem- 
brane proteins [2,3]. However, for some proteins the sig- 
nal sequence may trigger their direct transport across the 
phospholid bilayer without the involvement of mem- 
brane proteins [4]. 
In this short review, we will concentrate on the actual 
process of protein translocation which has been eluci- 
dated only recently. We will discuss the membrane com- 
ponents involved in co- and post-translational transloca- 
tion processes and speculate about mechanisms. 
2. Co-translational translocation of proteins 
Co-translational translocation occurs in all classes of 
organisms, although its importance may vary. Whereas 
it seems to be the predominant mode in mammals, in 
prokaryotes and in S. cerevisiae many proteins may be 
transported post-translationally. Evolutionary conserva- 
tion of the co-translational pathway is indicated by the 
ubiquitous occurrence of the SRP-mediated targeting 
pathway, as well as of essential membrane components 
[51. 
The mechanism of co-translational translocation has 
been best studied in the mammalian system. The recent 
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reconstitution of the translocation apparatus into prote- 
oliposomes, using purified membrane components from 
dog pancreas microsomes [6], indicates a surprising sim- 
plicity of the system. The basis machinery appears to 
consist of only three components: the SRP receptor, the 
Sec6lp complex and the TRAM protein. These compo- 
nents are sufficient for the translocation of all secretory 
proteins as well as for the insertion of all membrane 
proteins thus tested. 
The SRP receptor is most likely only required for the 
targeting process. It consists of two subunits that can 
both bind GTP [7-91. The a-subunit makes contact with 
the ribosome/nascent chain/SRP complex and its GTP- 
binding site is rquired for the transfer of the nascent 
chain into the membrane [lo]. The role of the B-subunit 
is still unknown. 
The Sec6lp complex is probably the core component 
of the translocation site. It consists of three subunits [6]. 
The large a-subunit was discovered to be a homolog of 
Sec6 1 p of S. cerevisiae which was found earlier in genetic 
screens for mutants defective in translocation [l l-131. 
Sec6la is predicted to span the membrane ten times. The 
/I- and y-subunits of the mammalian Sec6lp complex are 
small membrane proteins which are anchored by C-ter- 
minal hydrophobic tails. The y-subunit is homologous 
to the SSSl protein from S. cerevisiae and can function- 
ally replace it in yeast cells [ 141. Homologs of Sec6la, /? 
and y have also been found in a number of other eukar- 
yotes, indicating that a Sec6 1 p complex may be generally 
involved in protein translocation in these organisms [14]. 
Sec6la contacts polypeptide chains which are being 
transferred through the membrane [15-l 71. Photo- 
crosslinking experiments have demonstrated that Sec6la 
is the major neighbor of each of about 40 amino acids 
which follow the polypeptide segment located in the ribo- 
some (W. Mothes, S. Prehn and T.A. Rapoport, unpub- 
lished results). Thus, Sec6la may be the major, if not the 
only, component of a putative protein-conducting chan- 
nel that is linked to the ribosome. 
In mammals, the Sec6lp complex is likely to mediate 
the binding of the ribosome during co-translational 
translocation. The Sec6lp complex is tightly associated 
with membrane-bound ribosomes after solubilization of 
ER membranes [16]. This interaction can be induced by 
the targeting of a nascent chain to the membrane and the 
isolated Sec61-ribosome complex is dissociated under 
conditions identical to those needed for the release of 
ribosomes from the membranes. Sec6la is shielded by 
the membrane-bound ribosome and it shows the same 
remarkable resistance to protease treatment as the ribo- 
some-membrane link (K.-U. Kalies, D. Giirlich and 
T.A. Rapoport, unpublished results). Under physiologi- 
cal salt conditions, the Sec6lp complex accounts for the 
majority of binding sites for ribosomes lacking nascent 
chains. Finally, since some proteins, like preprolactin, 
require for their translocation only the presence of the 
SRP receptor and the Sec6lp complex in prote- 
oliposomes [6], it seems likely that the Sec6lp complex 
is sufficient for the binding of the translating ribosome. 
All these data suggest hat the Sec6lp complex is the 
long-sought after receptor for ribosomes and make it 
unlikely that other proposed proteins, such as p34 [18] 
or ~180 [19], play an essential role in the binding of 
ribosomes during translocation. 
The ribosome seems to make a tight seal with the 
membrane, probably by forming numerous contacts 
with the cytosolic loops of Sec6la. The membrane-in- 
serted nascent chain is not accessible to proteases or 
iodide ions added to the cytosolic compartment [20,21]. 
The tight association of the ribosome and the Sec6lp 
complex suggests that the nascent chain is transferred 
directly from the channel in the ribosome into the pro- 
tein-conducting channel in the membrane. Thus, the lat- 
ter may simply be an extension of the ribosomal channel, 
and the nascent chain may pass through the membrane 
in a vectorial manner because there is only one exit from 
the extended channel. According to such a model, a 
pumping, pulling or pushing machinery would not be 
required. However, it is possible that the nascent chain 
emerging in the ER lumen is bound by chaperone factors 
which facilitate transport [22]. 
The function of the third component of the mammal- 
ian translocation apparatus, the TRAM protein, is not 
fully understood. The TRAM protein is a multi-span- 
ning membrane protein that contacts a nascent chain 
during early phases of its transfer through the membrane 
[23]. In the case of preprolactin, it has been shown to 
interact predominantly with the hydrophilic part of the 
signal sequence preceding its hydrophobic core [24]. The 
presence of the TRAM protein is of variable importance 
for the translocation of different proteins into prote- 
oliposomes [6]. It is absolutely required for some pro- 
teins, like prepro-cc-factor, and only stimulatory for oth- 
ers, like preprolactin. The difference seems to depend on 
the structure of the signal sequence, although the precise 
features that determine the TRAM dependence have not 
yet been identified. 
One may speculate that the TRAM protein is involved 
in the membrane insertion of a nascent chain. A loop 
insertion, with one part of the hairpin being the hydro- 
phobic core of the signal sequence, is believed to be the 
first step in protein translocation. For secretory proteins 
and some membrane proteins, the N-terminal end of the 
loop stays in the cytosol and the C-terminal part moves 
through the membrane. For other membrane proteins, 
the N-terminal part of the loop is transferred across the 
membrane yielding the inverse orientation. TRAM could 
be involved in determining the orientation by interacting 
with one of the polypeptide regions flanking the hydro- 
phobic core of a signal sequence. It could also function 
during the insertion of polypeptide loops into the mem- 
brane in the case of multi-spanning proteins. 
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Fig. 1. A simplified scheme for co- and post-translational translocation pathways. Both modes of translocation in all classes of organisms require 
the Sec61/SecYp complex which presumably forms a protein-conducting channel. This core component interacts either with the ribosome during 
co-translational transport in mammals (and probably other organisms) or with other components during post-translational translocation in bacteria 
and yeast. In bacteria, the additional component, SecAp, is believed to push the polypeptide across the membrane in an ATP-dependent reaction. 
In yeast, the chaperone, BiP, in association with the Sec63p complex may consume ATP to pull the polypeptide across the membrane. The thick 
portion of the polypeptide chain indicates the hydrophobic core of the signal sequence. 
In addition to the Sec6lp complex and the TRAM 
protein, the mammalian translocation site contains other 
components. These include the signal peptidase and oli- 
gosaccharyltransferase, the two known enzymes in- 
volved in the modification of nascent polypeptide chains, 
as well as proteins of unknown function, such as the 
‘translocon-associated protein’ (TRAP) complex (previ- 
ously called SSR) (for review, see [l]). 
3. Post-translational translocation of proteins 
The post-translational mode of transport is best 
known for E. coli. Reconstitution experiments have 
shown that the machinery required for the translocation 
of proteins across the cytoplasmic membrane is related 
to the mammalian system mediating co-translational 
translocation [25,26]. Only two membrane components 
are essential: the peripheral membrane protein, SecAp, 
and the integral SecYp complex. 
SecAp is an ATPase (translocation ATPase) that ac- 
cepts the polypeptide chain from the cytosolic chaper- 
one, SecBp [27]. It is thought to push the polypeptide 
chain into the membrane by interacting with polypeptide 
segments and with the SecYp complex. Multiple rounds 
of ATP-driven binding and release steps may move the 
polypeptide chain across the membrane [28]. After the 
initial SecAp-dependent membrane insertion of a pol- 
ypeptide, an electrochemical potential can substitute, at 
least in part, for the SecAp ATPase. 
The SecYp complex consists of SecYp, SecEp and the 
Band1 protein [29]. It is structurally related to the Sec6lp 
complex of eukaryotes. SecYp is homologous to the 
mammalian Sec61 c1 and yeast Sec6lp [ 161, and is also 
adjacent to polypeptide chains crossing the membrane 
[30]. SecEp is predicted to span the membrane three 
times but only the last anchor is essential for its function 
[31], exactly the region that is similar in structure to 
Sec6ly and SSSlp [14]. Band I seems to be identical with 
p12 (W. Wickner, personal communication), a protein 
that stimulates translocation in vitro but is not essential 
[32]; its structure is not related to that of Sec61p. 
In addition to these components, genetic screens have 
identified SecDp and SecFp, two multi-spanning mem- 
brane proteins which are not essential for viability of 
E. coli cells [33]. These proteins may be involved in the 
maintainance of an electrochemical potential across the 
cytoplasmic membrane [34] or in the release of polypep- 
tide chains from the translocation site into the periplasm 
1351. 
Most likely, the translocation machinery in Gram- 
positive bacteria and in certain chloroplasts is very simi- 
lar to that of E. cob, as indicated by the existence of 
homologs to SecAp, SecYp and SecEp [14,16,36]. 
76 B. Jungnickel et al. IFEBS Letters 346 (1994) 73-77 
Post-translational translocation in S. cerevisiue may 
require a core component, the Sec6lp complex, similar 
to the SecYp complex in E. coli. Both Sec6lp and SSSlp 
are essential for the translocation of all proteins tested 
[11,37]. In addition to the core component, however, the 
post-translational translocation of prepro-a-factor in 
vitro also depends on the Sec63p complex [38] that is 
located in proximity to the Sec6lp complex [39]. The 
Sec63p complex consists of Sec63p, Sec7lp, Sec72p, 
Kar2p, and possibly Sec62p [38]. the Sec63, Sec71 and 
Sec62 proteins span the membrane 3, 1 and 2 times, 
respectively, Sec72p is a peripheral membrane protein, 
and Kar2p (BIP) is a lumenal chaperone [40-43]. Sec62p 
contacts polypeptides early during their translocation 
[15]. Kadp is thought to bind the polypeptide chain as 
it emerges in the ER lumen and to pull it across the 
membrane. 
Some mutations in the components of the Sec63p com- 
plex perturb translocation in vivo, even of proteins which 
can be transported only in a co-translational manner in 
vitro. Whether the Sec63p complex is involved in both 
modes of translocation is not yet clear. It is conceivable 
that it only functions in post-translational transport and 
that its effects in vivo on the co-translational mode are 
caused by the sequestration of the Sec6lp complex re- 
quired for both pathways. 
In conclusion, the Sec6USecY complex seems to be the 
core component in all known translocation pathways 
(see Fig. 1). For the co-translational mode, it simply 
binds to the ribosome and no further component is 
needed for the directional transport of a protein. For the 
post-translational mode, however, other different pro- 
teins seem to associate with the Sec611SecY core. One 
role of these additional components must be to provide 
a driving force for vectorial translocation, either by pull- 
ing the polypeptide chain across the membrane, as pro- 
posed for Kar2p in the yeast system, or by pushing it 
across, as suggested for SecAp in E. coli. The additional 
components may also function in place of the ribosome 
to prevent leakage of small molecules through the pro- 
tein-conducting channel, and in place of the SRP in sig- 
nal sequence recognition. 
4. Perspectives 
By now, most components of the translocation appa- 
ratus appear to have been identified. The basic machin- 
ery has turned out to be highly conserved in evolution 
and the existence of a protein-conducting channel is now 
likely, although its precise composition remains to be 
clarified. Despite the progress, the mechanism of translo- 
cation remains a mystery. 
Among the most urgent questions are those concern- 
ing the initiation of the translocation process: how is a 
polypeptide chain inserted into the translocation site? 
Does the signal sequence first interact with lipid before 
the chain is threaded into the channel? Which compo- 
nents determine the orientation of a membrane-inserted 
signal sequence? How is the protein-conducting channel 
opened? Does this involve the association or dissociation 
of membrane proteins? Equally important is the problem 
of termination of translocation: are factors needed to 
release polypeptide chains from the translocation site to 
allow its recycling for subsequent rounds of transport? 
When do hydrophobic segments of a membrane protein 
leave the translocation site to interact with the phospho- 
lipid? Does this occur as soon as they emerge into the 
protein-conducting channel or only after termination of 
translocation? Is there a function for the small subunits 
of the Sec6USecYp complex in gating the channel? 
The establishment of reconstitution systems for E. coli 
and mammals has paved the way to answer these ques- 
tions. Hopefully, similar reconstitution systems with pu- 
rified components will soon be available for the yeast 
system as well, which would permit a comparative study 
of co- and post-translational translocation pathways by 
the powerful combination of genetic and biochemical 
approaches. 
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